Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Appili Therapeutics Inc.
DescriptionSmall molecule antibiotic that inhibits bacterial translation by binding to the ribosomal 30S subunit
Molecular Target Ribosomal 30S subunit
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationPneumonia
Indication DetailsTreat Klebsiella pneumoniae
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today